Cooperative Agreement 2303802
- Novel Farms Inc. received a $256,000 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041) to develop microbe-based scaffolding for the generation of structured cell-based meat. The award, made on August 1, 2021, will support Novel Farms' research efforts through July 31, 2022 to produce meat products using cell culture techniques as an alternative to conventional animal agriculture. The NSF...
- Burlington Bio, Inc. received a $304,997 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084) on October 1, 2025, with a completion date of September 30, 2026. The company will develop a whey protein-based microcarrier platform designed to enable commercial-scale cultivated meat production. The project addresses a critical commercialization barrier in the cultivated meat industry by...
- This SBIR Phase I project, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), aims to develop a novel platform for accelerating the strain development process for precision fermentation. The $275,000 grant, awarded on January 15, 2025, will fund the recipient, Terraferma Foods, Inc., to leverage machine learning and experimental biology to enhance the industrial-scale production of animal proteins in yeast. The project...
- The National Science Foundation awarded Opera Bioscience, Inc. $275,000 under the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a low-cost bacterial production platform for manufacturing high purity recombinant proteins and growth factors. The award period runs from June 15, 2023 through May 31, 2024. Opera Bioscience will utilize this funding to demonstrate the ability of its innovative protein production platform to solve challenges in traditionally costly and...
- Tender Food, Inc. received a $256,000 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041). The grant funds fiber-assisted perfusion technology for cultured meat production. The NSF Directorate for Engineering seeks to improve quality of life and economic strength through engineering innovation and education. This award will support Tender Food's Boston Meats, Inc. division in developing new methods...
- Fybraworks Foods Inc. received a $256,000 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041) to develop a novel technology to manufacture animal-free muscle proteins in bacteria and yeasts. The goal of this February 2021 award is to produce sustainable sources of protein for human consumption using cell-based fermentation methods rather than traditional livestock agriculture. The one-year project...
- This SBIR Phase I award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program provides $273,111 to Hoofprint Biome, Inc. to develop a probiotic yeast technology that can reduce methane emissions from cattle by at least 30%, and potentially up to 98%. The technology involves screening and optimizing enzymes that restrict methane production in the cattle rumen, and then packaging these enzymes for delivery via a probiotic yeast. The...
- Federal Grant Award Summary Atlantic Fish Corporation received a $305,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships program (CFDA 47.084), effective October 1, 2025, through September 30, 2026. The project focuses on developing commercially viable cell lines for cultivated fish through bioengineering to enable scalable cellular seafood production. The company will conduct three primary...
- This SBIR Phase I project, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, is focused on the development of a novel mammalian cell-based nano-biological coating for implantable medical devices. The goal is to address the critical health and economic burden associated with implant-related infections by reducing or eliminating them through the use of this biocompatible and antimicrobial nano-biological coating. The $305,000...
- This Cooperative Agreement from the National Science Foundation will support Sasya Inc.'s research and development of sustainable production methods for high-performance dietary supplements through July 2024. Funded under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084), the $995,239 award aims to facilitate improved animal husbandry practices by providing natural supplements that can replace prophylactic antibiotics, drugs, and hormones in animal feed. The recipient will...
SBIR PHASE II: MICROBE-BASED SCAFFOLD FOR THE GENERATION OF STRUCTURED CELL-BASED MEAT -THE BROADER IMPACT OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE II PROJECT IS TO COMBAT THE PROFOUND NEGATIVE IMPACTS OF THE ANIMAL FARMING INDUSTRY THROUGH THE DEVELOPMENT OF NEW TECHNOLOGIES TO ADVANCE CULTIVATED MEAT PRODUCTION. APPROXIMATELY 30% OF THE EARTH?S SURFACE, 70% OF ALL ARABLE LAND, AND 29% OF THE GLOBAL FRESHWATER SUPPLY IS DEDICATED TO ANIMAL FARMING. LIVESTOCK IS RESPONSIBLE FOR 18% OF GLOBAL GREENHOUSE GAS EMISSIONS AND IS ONE OF THE LARGEST THREATS TO EARTH?S BIODIVERSITY. A SIGNIFICANT FRACTION (70%) OF ALL ANTIBIOTICS USED IN THE UNITED STATES ARE USED ON FARM ANIMALS AND THIS IS A PRIMARY CAUSE OF THE EMERGENCE OF ANTIBIOTIC-RESISTANT BACTERIA, LEAVING THE UNITED STATES WITH AN ECONOMIC BURDEN OF $55 BILLION AND A HEALTHCARE SYSTEM OVERWHELMED WITH 2,000,000 INFECTIONS, 250,000 HOSPITALIZATIONS, AND AT LEAST 23,000 DEATHS PER YEAR. AN EMERGING INDUSTRY POISED TO COMBAT THE NEGATIVE IMPACTS OF ANIMAL FARMING IS THE CULTIVATED MEAT INDUSTRY, WHICH IS ESTIMATED TO DECREASE ENERGY USE BY 7-45%, GREENHOUSE GASES BY 78-96%, LAND USE BY 99%, WATER USE BY 82-96%, AND COULD ELIMINATE THE NEED FOR ANTIBIOTICS USE IN MEAT PRODUCTION. THE PROJECT AIMS TO FURTHER DEVELOP A NOVEL TECHNOLOGY THAT WILL ALLOW FOR THE ECONOMICALLY FEASIBLE PRODUCTION OF CULTIVATED MEAT. THE PROPOSED PROJECT AIMS TO SOLVE ONE OF THE MAJOR BARRIERS IMPEDING THE ECONOMIC FEASIBILITY OF CULTIVATED MEAT ? CELL CULTURE MEDIA COST. CULTIVATED MEAT MUST BE PRICED COMPETITIVELY WITH CONVENTIONAL MEAT IF IT IS TO BE A VIABLE ALTERNATIVE TO MEAT PRODUCED VIA INDUSTRIAL FARMING. THUS, AS WITH ANIMAL FEED, CELL CULTURE MEDIA MUST BE AS INEXPENSIVE AS GRASS OR GOVERNMENT-SUBSIDIZED CORN TO ALLOW FOR THE PRODUCTION OF CULTIVATED MEAT AT A COMPARABLE PROFIT MARGIN. THE GOAL OF THIS PROJECT FOCUSES ON REDUCING MEDIA COSTS BY ELIMINATING EXPENSIVE MEDIA COMPONENTS THROUGH FURTHER DEVELOPMENT OF PROPRIETARY SCAFFOLDING TECHNOLOGY AND REDUCING THE OVERALL VOLUME OF MEDIA REQUIRED TO GENERATE CULTIVATED MEAT THROUGH THE ADAPTATION OF ULTRA-EFFICIENT, HIGH-DENSITY BIOREACTORS. TO DO THIS, THE SCAFFOLDING TECHNOLOGY GENERATED DURING THE PHASE I EFFORT WILL BE FURTHER DEVELOPED TO INCORPORATE GROWTH FACTORS, THE MOST EXPENSIVE ELEMENTS OF CELL CULTURE MEDIA, THEREBY REDUCING THE OVERALL COST OF MEDIA. THEN, THE SCAFFOLDS WILL BE ADAPTED FOR USE IN HIGH-DENSITY, PERFUSION-BASED BIOREACTORS THAT USE A FRACTION OF THE MEDIA AS CONVENTIONAL STIRRED-TANK BIOREACTORS, THEREBY REDUCING THE OVERALL CONSUMPTION OF MEDIA. TOGETHER, THESE TWO STRATEGIES WILL LOWER THE OVERALL COST OF CULTIVATED MEAT PRODUCTION. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE NOT PLANNED FOR THIS AWARD.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $375.0k | 9/12/25 | ||
| Not listed | $200.0k | 7/24/25 | ||
| Not listed | $8.0k | 7/10/24 | ||
| Not listed | $1.0m | 9/14/23 |